Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis.

Kota SaharaKatiuscha MerathDiamantis I TsilimigrasJ Madison HyerAlfredo GuglielmiLuca AldrighettiMatthew J WeissRyan C FieldsGeorge A PoultsidesShishir K MaithelItaru EndoTimothy M Pawliknull Other Members Of The U S Neuroendocrine Tumor Study Group

Published in: Journal of surgical oncology (2019)

CDFS of patients who underwent resection of NELM exponentially improved as patients survived additional years without recurrence. CDFS provides more accurate prognostic measures compared with traditional DFS measures.

Keyphrases

end stage renal disease
free survival
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
high resolution